← Back to home

Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

Clinical trials sponsored by Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation, explained in plain language.

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New TB vaccine aims to prevent active lung disease in adults

⭐️ VACCINE ⭐️ Ongoing

This Phase 3 trial tests the GamTBvac vaccine to prevent active pulmonary tuberculosis in adults aged 18 and older. The study includes people with and without a prior history of TB, comparing the vaccine to a placebo. Researchers will monitor how many participants develop active …

Phase: PHASE3 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: ⭐️ VACCINE ⭐️

Last updated Jul 08, 2026 00:00 UTC

Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

New TB vaccine aims to prevent active lung disease in adults